MedTrace Logo

Transcranial Direct Current Stimulation for Post-Stroke Aphasia

NCT02461355 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2019-05-09

Study results available
· View outcomes & findings →

Summary

This is a randomized, crossover design trial that will compare how anodal transcranial direct current stimulation (tDCS) versus sham tDCS administered during multiple sessions of scripting therapy affects the acquisition and retention of trained scripts.

Conditions

Interventions

BEHAVIORAL

Aphasia therapy

Aphasia therapy using a computerized scripting program

DEVICE

Anodal tDCS

Anodal transcranial direct current stimulation using the Chattanooga Ionto device

DEVICE

Sham tDCS

Sham transcranial direct current stimulation using the Chattanooga Ionto device

Sponsors & Collaborators

Principal Investigators

  • Tomoko Kitago, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02461355 on ClinicalTrials.gov